Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05313178 · ClinicalTrials.gov registry record · NA
Changes in Plasma Amino Acid Appearance After Adding Bacillus Coagulans GBI-30, 6086 to Milk Protein Concentrate
A NA study of Protein Malabsorption, sponsored by Lindenwood University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05313178 is a NA study of Protein Malabsorption that has completed, run by Lindenwood University. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05313178, a NA study of Protein Malabsorption, has completed, sponsored by Lindenwood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the pattern of plasma amino acid appearance after a two-week daily regimen of milk protein concentrate supplementation with and without the addition of Bacillus coagulans GBI-30, 6086 among older women.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Bacillus Coagulans GBI-30, 6086
Study Locations (1)
Missouri
- Lindenwood University - Saint Charles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2022-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05313178
The ClinicalTrials.gov registry entry for NCT05313178 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Protein Malabsorption appearing as the primary indexed condition, and to 1 intervention - of which Bacillus Coagulans GBI-30, 6086 is the first listed.
NCT05313178 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05313178 about?
NCT05313178 is a clinical study titled "Changes in Plasma Amino Acid Appearance After Adding Bacillus Coagulans GBI-30, 6086 to Milk Protein Concentrate". The purpose of this study is to examine the pattern of plasma amino acid appearance after a two-week daily regimen of milk protein concentrate supplementation with and without the addition of Bacillus coagulans GBI-30, 6086 among older women.
What is the current status of trial NCT05313178?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-11-20. Estimated completion is 2022-02-01.
What conditions does trial NCT05313178 study?
This clinical trial studies the following conditions: Protein Malabsorption.
What interventions are being tested in trial NCT05313178?
The interventions under investigation include: Bacillus Coagulans GBI-30, 6086 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05313178?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05313178 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.